11-2884935-AGCCGGGGCCGGGGCCGGG-AGCCGGGGCCGGG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001122630.2(CDKN1C):​c.516_521delCCCGGC​(p.Pro173_Ala174del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 900,922 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A172A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

CDKN1C
NM_001122630.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.666

Publications

0 publications found
Variant links:
Genes affected
CDKN1C (HGNC:1786): (cyclin dependent kinase inhibitor 1C) This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
CDKN1C Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • IMAGe syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, G2P, Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Beckwith-Wiedemann syndrome due to CDKN1C mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intrauterine growth restriction-short stature-early adult-onset diabetes syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Silver-Russell syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001122630.2
BP6
Variant 11-2884935-AGCCGGG-A is Benign according to our data. Variant chr11-2884935-AGCCGGG-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 412857.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000199 (27/135376) while in subpopulation NFE AF = 0.000292 (18/61720). AF 95% confidence interval is 0.000188. There are 0 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1CNM_001122630.2 linkc.516_521delCCCGGC p.Pro173_Ala174del disruptive_inframe_deletion Exon 2 of 4 ENST00000440480.8 NP_001116102.1 P49918-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1CENST00000440480.8 linkc.516_521delCCCGGC p.Pro173_Ala174del disruptive_inframe_deletion Exon 2 of 4 1 NM_001122630.2 ENSP00000411257.2 P49918-2

Frequencies

GnomAD3 genomes
AF:
0.000199
AC:
27
AN:
135376
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000189
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000716
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000129
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000292
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
122
AF XY:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000132
AC:
101
AN:
765546
Hom.:
0
AF XY:
0.000127
AC XY:
46
AN XY:
362944
show subpopulations
African (AFR)
AF:
0.000410
AC:
6
AN:
14626
American (AMR)
AF:
0.00
AC:
0
AN:
4428
Ashkenazi Jewish (ASJ)
AF:
0.000122
AC:
1
AN:
8218
East Asian (EAS)
AF:
0.0000781
AC:
1
AN:
12798
South Asian (SAS)
AF:
0.0000691
AC:
1
AN:
14462
European-Finnish (FIN)
AF:
0.000153
AC:
2
AN:
13094
Middle Eastern (MID)
AF:
0.00209
AC:
4
AN:
1918
European-Non Finnish (NFE)
AF:
0.000120
AC:
80
AN:
667256
Other (OTH)
AF:
0.000209
AC:
6
AN:
28746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000199
AC:
27
AN:
135376
Hom.:
0
Cov.:
32
AF XY:
0.000152
AC XY:
10
AN XY:
65762
show subpopulations
African (AFR)
AF:
0.000189
AC:
7
AN:
37112
American (AMR)
AF:
0.0000716
AC:
1
AN:
13968
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3200
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4532
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4194
European-Finnish (FIN)
AF:
0.000129
AC:
1
AN:
7746
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
254
European-Non Finnish (NFE)
AF:
0.000292
AC:
18
AN:
61720
Other (OTH)
AF:
0.00
AC:
0
AN:
1846
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 23, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

CDKN1C-related disorder Benign:1
Mar 04, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Beckwith-Wiedemann syndrome Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDKN1C: BP3 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.67
Mutation Taster
=185/15
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878853629; hg19: chr11-2906165; API